Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
18.1M
-
Shares change
-
-180K
-
Total reported value, excl. options
-
$2.31B
-
Value change
-
-$21.5M
-
Put/Call ratio
-
0.59
-
Number of buys
-
80
-
Number of sells
-
-92
-
Price
-
$128.12
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2014
214 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2014.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.1M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.8M shares), VANGUARD GROUP INC (1.15M shares), ARIEL INVESTMENTS, LLC (1.02M shares), LEVIN CAPITAL STRATEGIES, L.P. (956K shares), ROYCE & ASSOCIATES LLC (873K shares), Champlain Investment Partners, LLC (800K shares), WELLS FARGO & COMPANY/MN (762K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (598K shares), BlackRock Institutional Trust Company, N.A. (588K shares), and BlackRock Fund Advisors (571K shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.